期刊文献+

削弱高密度脂蛋白胆固醇心血管保护作用的影响因素分析 被引量:2

下载PDF
导出
摘要 目的研究高水平高密度脂蛋白胆固醇(HDL-C)冠心病患者的临床特征及血脂水平,分析削弱HDL-C心血管保护作用的影响因素。方法选择80例HDL-C≥1.56 mmol/L(60 mg/dl)的患者,按冠状动脉造影结果分为冠心病组46例,对照组34例,测定血脂和血糖指标,详细记录临床特征并进行分析。结果与对照组比较,冠心病组的体重指数(BMI)显著大于对照组(P<0.01),甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)水平显著高于对照组(P<0.01),总胆固醇(TC)和载脂蛋白B(ApoB)水平亦高于对照组(P<0.05);HDL-C与饮酒呈正相关(r=0.227,P<0.001),与BMI、TG呈负相关(r=-0.159、-0.287,均P<0.001);LDL-C、BMI及年龄与冠心病发病的危险性独立相关。结论部分高水平HDL-C人群受BMI、TG等因素的影响,削弱了HDL-C的心血管保护作用而发生冠心病。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2007年第21期2101-2103,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献10

  • 1刘乃丰.氧化修饰LDL在动脉粥样硬化发生中的作用[J].中国病理生理杂志,1994,10(1):104-107. 被引量:15
  • 2Bersot TP,Pepin GM,Mahley RW.Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol[J].Am Heart J,2003 ;146(6):1052-9.
  • 3Wierzbicki AS,Mikhailidis DP.Beyond LDL-C-the importance of raising HDL-C[J].Curr Med Res Opin,2002;18:36-44.
  • 4Price MJ,Shah PK.New strategies in managing and preventing atherosclerosis:focus on HDL[J].Rev Cardiovasc Med,2002 ;3:129-37.
  • 5von Eckardstein A,Hersberger M,Rohrer L.Current understanding of the metabolism and biological actions of HDL[J].Curr Opin Clin Nutr Metab Care,2005 ;8(2):147-52.
  • 6Bittner V,Simon JA,Fonq J,et al.Correlates of high HDL cholesterol among women with coronary heart disease[J].Am Heart J,2000;139 (2 Pt 1):288-96.
  • 7Navab M,Ananthramaiah GM,Reddv ST,et al.The double jeopardy of HDL[J].Ann Med,2005 ;37 (3):173-8.
  • 8Karlsson H,Leanderson P,Tagesson C,et al.Lipoproteomics Ⅱ:Mapping of proteins in high density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry[J].Proteomics,2005 ;5(5):1431-45.
  • 9勾蓝图,傅明德,徐燕华,颜丙玉,杨雨叶,杨鲁川.动脉粥样硬化低危与高危人群血清高密度脂蛋白亚类组成差异的研究[J].临床心血管病杂志,2004,20(9):559-561. 被引量:4
  • 10Yang Y,Yan B,Fu M,et al.Relationship between plasma lipid concentrations and HDL subclasses[J].Clin Chim Acta,2005 ;354(1):49-58.

二级参考文献12

  • 1[1]Cheung M C, Brown B G, Wolf A C. Altered particle size distribution of apoA Ⅰ -containing HDL subpopulations in patients with coronary heart disease. Arterio scler Thromb Vasc Biol, 1991,32: 383- 394.
  • 2[3]Adult Treatmeat Panel. Executive summary of the third report of NCEP, expert panel on detection, evaluation and treatmeat of high blood cholesterol in adults. Adult Treatmeat PanelⅢ. JAMA, 2001,285:2486-2497.
  • 3[4]Friedewald W F, Levy R I, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972,18:499 - 502.
  • 4[6]Saidi Y, Sich D, Camproux A, et al. Interrelationships between postprandial lipoprotein B:C Ⅱ particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia. Metabolism, 1998,48 : 60-67.
  • 5[7]Lee M, Kim J. Studies on the plasma lipid profiles, and LCAT and CETP activities according to Hyperlipoproteinemia phenotypes (HLP). Atherosclerosis, 2001,159:381-389.
  • 6[8]Miida T, Yamaguchi Y, Tsuda T, et al. High preβ1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by alow-cholesterol diet. Atherosclerosis, 1998,138 : 129- 134.
  • 7[9]Xu Y H, Fu M D. Alterations of HDL subclasses in hyperlipidemia. Clin Chim Acta, 2003,332: 95- 102.
  • 8吴新伟,傅明德.胆固醇逆向转运的分子机制[J].生理科学进展,1998,29(4):361-363. 被引量:10
  • 9吴新伟,傅明德,刘秉文,邓萍.人血清高密度脂蛋白亚类免疫印迹检测法[J].中国动脉硬化杂志,1999,7(3):253-255. 被引量:46
  • 10徐燕华,傅明德,吴新伟,任艳.2型糖尿病患者血清HDL亚类组成的研究[J].中国糖尿病杂志,2001,9(3):160-162. 被引量:18

共引文献17

同被引文献36

  • 1代方国,赵晓山,罗仁,张曦倩,罗云坚,崔丽娟,付婷婷.构建中国汉族人亚健康状态肾阴虚证的DNA消减文库[J].中国临床康复,2005,9(19):97-99. 被引量:8
  • 2赵晓山,罗仁,张曦倩,罗云坚,黄穗平,李玉萍,崔丽娟.肾阴虚证cDNA文库的构建[J].中国现代医学杂志,2007,17(3):285-290. 被引量:9
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 4Meeus M,Nijs J,McGregor N,et al.Unravelling intracellular immune dysfunctions in chronic fatigue syndrome:interactions between protein kinase R activity, RNase L cleavage and e- lastase activity and their clinical relevance[J]. In Vivo,2008, 22(11):115 -121.
  • 5Maes M,Mihaylova I,Leuins JC.Inereased serum lgM antibod- ies directed against phosphatidyl inositol (Pi) in chronic fa- tigue syndrome(CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor under- pinning the comorbidity between both CFS and depression IJ]. Neuro Endocrinol Lett,2007,28 (6): 861-867.
  • 6Mihaylova I,DeRuyter M,Rummens JL,et al.Decreased ex- pression of CD69 in chronic fatigue syndrome in relation to inflammatory markers:evidence for a severe disorder in the early activation of 3' lymphocytes and natural killer cells [J]. Neuro Endocrinol Lett, 2007,28 (4) : 477-483.
  • 7Richards RS,Wang L,Jelinek H. Erythrocyte oxidative dam- age in chronic fatigue syndrome[Jl. Arch Med Res, 2007,38 ( 1 ) : 94-98.
  • 8KelT JR,Petty R,Burke B,et al. Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic En- cephalomyelitis[J]. J Infect Dis, 2008,197 ( 8 ) : 1171-1184.
  • 9Sundstro MJ,Sullivan LD,Agostion RB,et al.Relations of serum uric acid to longtudinal blood pressure tracking and hypertention incidence [J].Hypertention,2005,45 ( 1 ) :28- 33.
  • 10Price M J, Shah PK. New strategies in managing and prevent- ing stherosclerosis: focus on HDL[J]. Rev Cardiovasc Med, 2002,3 : 129-137.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部